dihexa clinical trials status 2025 or 2026 Market Size to Promote USD 174.18 Billion by 2035 Redefining Access in Clinical Trials

Neuropathic Pain: For patients with nerve-based pain, including conditions like peripheral neuropathy or chemotherapy-induced peripheral neuropathy, peptides that target nerve repair pathways show remarkable potential without the dependency risks of opioids

No published research exists on this exact combination yet

Reduces chronic inflammation FOXO4-DRI reduces chronic inflammation by targeting and eliminating senescent cells, which are known to be major contributors to inflammation in the body

A high-throughput screening method of a library of 10,000 small organic molecules identified 29 compounds that bind to Hp-Fld and stabilize its structure

Ligament injuries heal more slowly than tendons due to even more limited blood supply and constant mechanical stress during recovery